Sunesis Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-96,299
| Closed | -$1.51M | – | 50 |
|
|
2024
Q1 | $1.51M | Hold |
96,299
| – | – | 0.89% | 19 |
|
|
2023
Q4 | $1.55M | Hold |
96,299
| – | – | 0.95% | 19 |
|
|
2023
Q3 | $1.22M | Buy |
+96,299
| New | +$1.33M | 0.87% | 18 |
|
|
2023
Q1 | $1.49M | Hold |
96,299
| – | – | 1.07% | 13 |
|
|
2022
Q4 | $1.58M | Hold |
96,299
| – | – | 1.01% | 17 |
|
|
2022
Q3 | $1.78M | Hold |
96,299
| – | – | 1.23% | 12 |
|
|
2022
Q2 | $1.27M | Hold |
96,299
| – | – | 0.82% | 27 |
|
|
2022
Q1 | $893K | Hold |
96,299
| – | – | 0.52% | 32 |
|
|
2021
Q4 | $941K | Hold |
96,299
| – | – | 0.69% | 25 |
|
|
2021
Q3 | $3.27M | Hold |
96,299
| – | – | 2.53% | 7 |
|
|
2021
Q2 | $3.53M | Hold |
96,299
| – | – | 2.7% | 7 |
|
|
2021
Q1 | $4.32M | Hold |
96,299
| – | – | 3.45% | 6 |
|
|
2020
Q4 | $5.5M | Hold |
96,299
| – | – | 4.45% | 5 |
|
|
2020
Q3 | $4.94M | Hold |
96,299
| – | – | 4.39% | 5 |
|
|
2020
Q2 | $5.75M | Hold |
96,299
| – | – | 5.29% | 4 |
|
|
2020
Q1 | $3.96M | Hold |
96,299
| – | – | 3.99% | 6 |
|
|
2019
Q4 | $5.99M | Hold |
96,299
| – | – | 5.46% | 4 |
|
|
2019
Q3 | $3.27M | Hold |
96,299
| – | – | 3.39% | 6 |
|
|
2019
Q2 | $2.17M | Hold |
96,299
| – | – | 2.33% | 8 |
|
|
2019
Q1 | $2.23M | Hold |
96,299
| – | – | 2.25% | 10 |
|
|
2018
Q4 | $2.02M | Hold |
96,299
| – | – | 2.2% | 11 |
|
|
2018
Q3 | $3.73M | Hold |
96,299
| – | – | 3.76% | 5 |
|
|
2018
Q2 | $3.79M | Buy |
+96,299
| New | +$2.83M | 4.65% | 6 |
|
Other funds holding DCPH
Sunesis Advisors's DCPH Position: Q2 2024 in Review
Sunesis Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 96,299 shares — an estimated $1.51M sold.
Sunesis Advisors first reported a position in DCPH in Q2 2018 and held it in 23 quarters. The position peaked at $5.99M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Sunesis Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Sunesis Advisors sold 96,299 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.51M.
- Sunesis Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
- Sunesis Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.99M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Sunesis Advisors's 13F filing for Q2 2024, filed 16 Jul 2024.